Arvinas, Inc. (ARVN)
9.20
+0.10
(+1.10%)
USD |
NASDAQ |
May 21, 15:51
Arvinas Research and Development Expense (TTM) : 252.10M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.52B |
| Rigel Pharmaceuticals, Inc. | 36.54M |
| EyePoint, Inc. | 234.61M |
| Elanco Animal Health, Inc. | 371.00M |
| Corcept Therapeutics, Inc. | 260.44M |